ACADIA HEALTHCARE CO INC (ACHC) Stock Fundamental Analysis
NASDAQ:ACHC - Nasdaq - US00404A1097 - Common Stock - Currency: USD
ACHC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. ACHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. ACHC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ACHC was profitable.
In the past year ACHC had a positive cash flow from operations.
In multiple years ACHC reported negative net income over the last 5 years.
In the past 5 years ACHC always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.05%, ACHC is in the better half of the industry, outperforming 63.73% of the companies in the same industry.
ACHC has a Return On Equity of 6.17%. This is in the better half of the industry: ACHC outperforms 64.71% of its industry peers.
ACHC has a better Return On Invested Capital (6.43%) than 65.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACHC is in line with the industry average of 9.62%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 6.17% | ||
| ROIC | 6.43% |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
1.3 Margins
ACHC has a better Profit Margin (5.94%) than 82.35% of its industry peers.
In the last couple of years the Profit Margin of ACHC has grown nicely.
With an excellent Operating Margin value of 14.95%, ACHC belongs to the best of the industry, outperforming 87.25% of the companies in the same industry.
In the last couple of years the Operating Margin of ACHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.95% | ||
| PM (TTM) | 5.94% | ||
| GM | N/A |
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ACHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ACHC has more shares outstanding
Compared to 5 years ago, ACHC has more shares outstanding
ACHC has a worse debt/assets ratio than last year.
2.2 Solvency
ACHC has an Altman-Z score of 1.27. This is a bad value and indicates that ACHC is not financially healthy and even has some risk of bankruptcy.
ACHC has a Altman-Z score of 1.27. This is in the lower half of the industry: ACHC underperforms 66.67% of its industry peers.
ACHC has a Debt/Equity ratio of 0.72. This is a neutral value indicating ACHC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, ACHC is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.27 |
ROIC/WACC0.79
WACC8.15%
2.3 Liquidity
ACHC has a Current Ratio of 1.35. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
ACHC has a Current ratio of 1.35. This is comparable to the rest of the industry: ACHC outperforms 44.12% of its industry peers.
ACHC has a Quick Ratio of 1.34. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
ACHC has a Quick ratio (1.34) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
The earnings per share for ACHC have decreased strongly by -18.75% in the last year.
Measured over the past years, ACHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.21% on average per year.
ACHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.48%.
ACHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.45% yearly.
EPS 1Y (TTM)-18.75%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-52.38%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%0.32%
3.2 Future
Based on estimates for the next years, ACHC will show a small growth in Earnings Per Share. The EPS will grow by 5.66% on average per year.
ACHC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.46% yearly.
EPS Next Y-17.88%
EPS Next 2Y-3.75%
EPS Next 3Y0.17%
EPS Next 5Y5.66%
Revenue Next Year5.56%
Revenue Next 2Y7.05%
Revenue Next 3Y7.15%
Revenue Next 5Y8.46%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.74, the valuation of ACHC can be described as very cheap.
ACHC's Price/Earnings ratio is rather cheap when compared to the industry. ACHC is cheaper than 97.06% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.60, ACHC is valued rather cheaply.
ACHC is valuated cheaply with a Price/Forward Earnings ratio of 7.24.
ACHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACHC is cheaper than 93.14% of the companies in the same industry.
ACHC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.74 | ||
| Fwd PE | 7.24 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACHC indicates a rather cheap valuation: ACHC is cheaper than 87.25% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.56 |
4.3 Compensation for Growth
ACHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.76
EPS Next 2Y-3.75%
EPS Next 3Y0.17%
5. Dividend
5.1 Amount
ACHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
22.13
-0.64 (-2.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners109.62%
Inst Owner Change-0.2%
Ins Owners1%
Ins Owner Change8.66%
Market Cap2.04B
Analysts82
Price Target43.71 (97.51%)
Short Float %10.59%
Short Ratio3.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.13%
Min EPS beat(2)-12.21%
Max EPS beat(2)9.95%
EPS beat(4)2
Avg EPS beat(4)-0.27%
Min EPS beat(4)-12.21%
Max EPS beat(4)9.95%
EPS beat(8)6
Avg EPS beat(8)1.47%
EPS beat(12)9
Avg EPS beat(12)9.78%
EPS beat(16)11
Avg EPS beat(16)7.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.22%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.51%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)5
Avg Revenue beat(16)-0.8%
PT rev (1m)-7.6%
PT rev (3m)-20.35%
EPS NQ rev (1m)-8.94%
EPS NQ rev (3m)-23.2%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-2.28%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-3.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.74 | ||
| Fwd PE | 7.24 | ||
| P/S | 0.65 | ||
| P/FCF | N/A | ||
| P/OCF | 4.41 | ||
| P/B | 0.67 | ||
| P/tB | 2.97 | ||
| EV/EBITDA | 6.56 |
EPS(TTM)2.86
EY12.92%
EPS(NY)3.06
Fwd EY13.82%
FCF(TTM)-2.82
FCFYN/A
OCF(TTM)5.02
OCFY22.68%
SpS34.26
BVpS33.02
TBVpS7.45
PEG (NY)N/A
PEG (5Y)0.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 6.17% | ||
| ROCE | 8.32% | ||
| ROIC | 6.43% | ||
| ROICexc | 6.54% | ||
| ROICexgc | 11.31% | ||
| OM | 14.95% | ||
| PM (TTM) | 5.94% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ROICexc(3y)8.08%
ROICexc(5y)7.37%
ROICexgc(3y)16.06%
ROICexgc(5y)14.72%
ROCE(3y)10.25%
ROCE(5y)9.25%
ROICexcg growth 3Y-4.56%
ROICexcg growth 5Y16.02%
ROICexc growth 3Y1.65%
ROICexc growth 5Y14.56%
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.46 | ||
| Cap/Depr | 450.84% | ||
| Cap/Sales | 22.89% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 73.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 1.27 |
F-Score6
WACC8.15%
ROIC/WACC0.79
Cap/Depr(3y)344.44%
Cap/Depr(5y)299.77%
Cap/Sales(3y)15.9%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.75%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-52.38%
EPS Next Y-17.88%
EPS Next 2Y-3.75%
EPS Next 3Y0.17%
EPS Next 5Y5.66%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%0.32%
Revenue Next Year5.56%
Revenue Next 2Y7.05%
Revenue Next 3Y7.15%
Revenue Next 5Y8.46%
EBIT growth 1Y-9.84%
EBIT growth 3Y9.61%
EBIT growth 5Y10.7%
EBIT Next Year22.45%
EBIT Next 3Y13.59%
EBIT Next 5Y11.46%
FCF growth 1Y-820.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.81%
OCF growth 3Y-29.78%
OCF growth 5Y-15.9%